OM
Opaleye Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-897,000
| Closed | -$7.19M | – | 49 |
|
|
2024
Q2 | $7.19M | Hold |
897,000
| – | – | 1.64% | 19 |
|
|
2024
Q1 | $13.3M | Hold |
897,000
| – | – | 2.9% | 8 |
|
|
2023
Q4 | $7.29M | Buy |
897,000
+287,000
| +47% | +$2.33M | 1.94% | 15 |
|
|
2023
Q3 | $2.78M | Buy |
610,000
+189,000
| +45% | +$860K | 0.9% | 30 |
|
|
2023
Q2 | $2.96M | Hold |
421,000
| – | – | 0.71% | 33 |
|
|
2023
Q1 | $2.57M | Buy |
+421,000
| New | +$2.57M | 0.77% | 33 |
|
|
2018
Q4 | – | Sell |
-325,000
| Closed | -$3.66M | – | 51 |
|
|
2018
Q3 | $3.66M | Buy |
+325,000
| New | +$3.66M | 0.93% | 31 |
|
|
2017
Q2 | – | Sell |
-230,000
| Closed | -$1.71M | – | 44 |
|
|
2017
Q1 | $1.71M | Sell |
230,000
-70,000
| -23% | -$521K | 0.85% | 32 |
|
|
2016
Q4 | $2.09M | Buy |
300,000
+20,000
| +7% | +$139K | 1.23% | 25 |
|
|
2016
Q3 | $2.3M | Buy |
280,000
+20,000
| +8% | +$165K | 1.21% | 31 |
|
|
2016
Q2 | $2.11M | Buy |
+260,000
| New | +$2.11M | 1.41% | 26 |
|
|
2015
Q2 | – | Sell |
-200,000
| Closed | -$2.42M | – | 48 |
|
|
2015
Q1 | $2.42M | Buy |
+200,000
| New | +$2.42M | 1.12% | 28 |
|